The CDC recently extended emergency approval of the Pfizer-BioNTech COVID-19 vaccine booster for patients ages 16 and 17. The CDC approval recommends patients in this age group receive a COVID vaccine booster six months after their initial COVID vaccine series.
The vaccine booster aims to shore up waning immunity against the COVID-19 virus. The CDC did not issue information about the booster’s effectiveness against specific emerging variants. However, early studies show the booster supports prevention against COVID variants. As with the initial vaccine, the booster strengthens and broadens protection.
Qualifications for the Pfizer-BioNTech COVID Vaccine Booster
- Ages 16 and older
- Six months post completion of the initial vaccine series
Patients over 18 may receive approved booster shots from Pfizer-BioNTech, Johnson & Johnson, or Moderna. However, patients ages 16 and 17 may only receive the Pfizer-BioNTech vaccine booster.
The Pfizer-BioNTech booster dosage for all patients ages 16 and over is the same as the individual shots in the first vaccine series.
Why Do Patients Need a COVID Booster?
Studies show that the vaccine’s effectiveness decreases over time. The COVID vaccine booster offers additional protection against the virus. The new recommendation for vaccine boosters for patients 16 years old and older supports public health goals to fight the COVID-19 virus.
Is the COVID Vaccine Booster Safe?
As with the initial COVID vaccines, the boosters are safe and effective. The CDC approved emergency use of the booster for patients ages 16 and over based on the safety and effectiveness of the vaccine.
Patients may experience side effects common with vaccines, including pain or swelling at the injection site, tiredness, headaches, fever, or muscle pain. These side effects are a normal part of the immune system’s response to the vaccine.
Schedule Your Vaccine Booster Today at Emergent Testing.